SAVA Cassava Sciences, Inc.
Healthcare$1.32+0.00%OpenMarket Cap: $63.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.93
P/S
0.00
EV/EBITDA
0.29
DCF Value
$1.15
FCF Yield
-141.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-99.8%
ROA
-71.9%
ROIC
-120.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $0.00 | $-10.3M | $— | — |
| Q4 null | $0.00 | Infinity% | $-13.6M | $-12.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-95.4M | $-91.0M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-11.9M | $-10.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-45.4M | $-44.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-24.6M | $-23.4M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-29.5M | $-27.6M | $— | — |
| FY null | $0.00 | NaN% | $-141.4M | $-24.3M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-30.6M | $-27.9M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-61.4M | $6.2M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-19.9M | $25.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-22.8M | $-20.9M | $-0.50 | — |